GBT

Global Blood Therapeutics, Inc.
GBT

Overview Fund Activity
Delisted

GBT was delisted on the 4th of October, 2022.

Back to rankings

68 hedge funds and large institutions have $470M invested in Global Blood Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 10 closing their positions.

Holders
68
Holders Change
+9
Holders Change %
+15.25%
% of All Funds
1.79%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
20
Increased
27
Reduced
17
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
JHIU
1
Janus Henderson Investors US
Colorado
$22.6M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$16.3M
3
Wellington Management Group
3
Wellington Management Group
Massachusetts
$32.3M
4
GGHC
4
Gilder Gagnon Howe & Co
New York
$9.6M
5
DM
5
Deerfield Management
New York
$37.6M

Top Sellers

1
RIM
1
RS Investment Management
California
$0
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$0
3
BA
3
BlackRock Advisors
Delaware
$78K
4
BG
4
BlackRock Group
United Kingdom
$35K
5
Millennium Management
5
Millennium Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Tudor Investment Corp
76
Tudor Investment Corp
Connecticut
– -$346K -8,200 Closed
Barclays
77
Barclays
United Kingdom
– -$68K -1,620 Closed
Royal Bank of Canada
78
Royal Bank of Canada
Ontario, Canada
– -$17K -400 Closed
1 2 3
4